Global and Japan Intra-Uterine Contraceptive Devices Market Insights, Forecast to 2026

Publisher Name :
Date: 15-Sep-2020
No. of pages: 142
Inquire Before Buying

Intra-Uterine Contraceptive Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Intra-Uterine Contraceptive Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Intra-Uterine Contraceptive Devices market is segmented into

- Copper IUCD

- Hormonal IUCD

Segment by Application, the Intra-Uterine Contraceptive Devices market is segmented into

- Hospitals

- Gynaecology clinics

- Community healthcare

Regional and Country-level Analysis

The Intra-Uterine Contraceptive Devices market is analysed and market size information is provided by regions (countries).

The key regions covered in the Intra-Uterine Contraceptive Devices market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Intra-Uterine Contraceptive Devices Market Share Analysis

Intra-Uterine Contraceptive Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intra-Uterine Contraceptive Devices business, the date to enter into the Intra-Uterine Contraceptive Devices market, Intra-Uterine Contraceptive Devices product introduction, recent developments, etc.

The major vendors covered:

- Bayer AG

- Teva Pharmaceuticals Industries

- Mona Lisa N.V.

- DKT International

- Egemen International

- Melbea AG

- Ocon Medical Ltd.

- Pregna International Limited

- Medical Engineering Corporation SA

- SMB Corporation and Meril Life Sciences Pvt. Ltd.

- Medu Scientific Ltd, China RH Contraceptives Co., Ltd

- Sanghai Jolly Medical Education Co., Ltd

- Bernstein Leibhard LLP

- Zheijang Daji Medical Instruments, Ltd.

- Nimble International

- AME Line, Technico

- Cepeo

- Contraceptivos

- Injeflex Ind And Com Ltda

- Bersil

- Amed

Global and Japan Intra-Uterine Contraceptive Devices Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Intra-Uterine Contraceptive Devices Product Introduction
1.2 Market Segments
1.3 Key Intra-Uterine Contraceptive Devices Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Intra-Uterine Contraceptive Devices Market Size Growth Rate by Type
1.4.2 Copper IUCD
1.4.3 Hormonal IUCD
1.5 Market by Application
1.5.1 Global Intra-Uterine Contraceptive Devices Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Gynaecology clinics
1.5.4 Community healthcare
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intra-Uterine Contraceptive Devices Market Size, Estimates and Forecasts
2.1.1 Global Intra-Uterine Contraceptive Devices Revenue 2015-2026
2.1.2 Global Intra-Uterine Contraceptive Devices Sales 2015-2026
2.2 Global Intra-Uterine Contraceptive Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Intra-Uterine Contraceptive Devices Historical Market Size by Region (2015-2020)
2.3.1 Global Intra-Uterine Contraceptive Devices Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Intra-Uterine Contraceptive Devices Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Intra-Uterine Contraceptive Devices Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Intra-Uterine Contraceptive Devices Sales Forecast by Region (2021-2026)
2.4.2 Global Intra-Uterine Contraceptive Devices Revenue Forecast by Region (2021-2026)
3 Global Intra-Uterine Contraceptive Devices Competitor Landscape by Players
3.1 Global Top Intra-Uterine Contraceptive Devices Sales by Manufacturers
3.1.1 Global Intra-Uterine Contraceptive Devices Sales by Manufacturers (2015-2020)
3.1.2 Global Intra-Uterine Contraceptive Devices Sales Market Share by Manufacturers (2015-2020)
3.2 Global Intra-Uterine Contraceptive Devices Manufacturers by Revenue
3.2.1 Global Intra-Uterine Contraceptive Devices Revenue by Manufacturers (2015-2020)
3.2.2 Global Intra-Uterine Contraceptive Devices Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intra-Uterine Contraceptive Devices Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Intra-Uterine Contraceptive Devices Revenue in 2019
3.2.5 Global Intra-Uterine Contraceptive Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Intra-Uterine Contraceptive Devices Price by Manufacturers
3.4 Global Intra-Uterine Contraceptive Devices Manufacturing Base Distribution, Product Types
3.4.1 Intra-Uterine Contraceptive Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intra-Uterine Contraceptive Devices Product Type
3.4.3 Date of International Manufacturers Enter into Intra-Uterine Contraceptive Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Intra-Uterine Contraceptive Devices Market Size by Type (2015-2020)
4.1.1 Global Intra-Uterine Contraceptive Devices Sales by Type (2015-2020)
4.1.2 Global Intra-Uterine Contraceptive Devices Revenue by Type (2015-2020)
4.1.3 Intra-Uterine Contraceptive Devices Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Intra-Uterine Contraceptive Devices Market Size Forecast by Type (2021-2026)
4.2.1 Global Intra-Uterine Contraceptive Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Intra-Uterine Contraceptive Devices Revenue Forecast by Type (2021-2026)
4.2.3 Intra-Uterine Contraceptive Devices Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Intra-Uterine Contraceptive Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Intra-Uterine Contraceptive Devices Market Size by Application (2015-2020)
5.1.1 Global Intra-Uterine Contraceptive Devices Sales by Application (2015-2020)
5.1.2 Global Intra-Uterine Contraceptive Devices Revenue by Application (2015-2020)
5.1.3 Intra-Uterine Contraceptive Devices Price by Application (2015-2020)
5.2 Intra-Uterine Contraceptive Devices Market Size Forecast by Application (2021-2026)
5.2.1 Global Intra-Uterine Contraceptive Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Intra-Uterine Contraceptive Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Intra-Uterine Contraceptive Devices Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Intra-Uterine Contraceptive Devices Market Size YoY Growth 2015-2026
6.1.1 Japan Intra-Uterine Contraceptive Devices Sales YoY Growth 2015-2026
6.1.2 Japan Intra-Uterine Contraceptive Devices Revenue YoY Growth 2015-2026
6.1.3 Japan Intra-Uterine Contraceptive Devices Market Share in Global Market 2015-2026
6.2 Japan Intra-Uterine Contraceptive Devices Market Size by Players (International and Local Players)
6.2.1 Japan Top Intra-Uterine Contraceptive Devices Players by Sales (2015-2020)
6.2.2 Japan Top Intra-Uterine Contraceptive Devices Players by Revenue (2015-2020)
6.3 Japan Intra-Uterine Contraceptive Devices Historic Market Review by Type (2015-2020)
6.3.1 Japan Intra-Uterine Contraceptive Devices Sales Market Share by Type (2015-2020)
6.3.2 Japan Intra-Uterine Contraceptive Devices Revenue Market Share by Type (2015-2020)
6.3.3 Japan Intra-Uterine Contraceptive Devices Price by Type (2015-2020)
6.4 Japan Intra-Uterine Contraceptive Devices Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Intra-Uterine Contraceptive Devices Sales Forecast by Type (2021-2026)
6.4.2 Japan Intra-Uterine Contraceptive Devices Revenue Forecast by Type (2021-2026)
6.4.3 Japan Intra-Uterine Contraceptive Devices Price Forecast by Type (2021-2026)
6.5 Japan Intra-Uterine Contraceptive Devices Historic Market Review by Application (2015-2020)
6.5.1 Japan Intra-Uterine Contraceptive Devices Sales Market Share by Application (2015-2020)
6.5.2 Japan Intra-Uterine Contraceptive Devices Revenue Market Share by Application (2015-2020)
6.5.3 Japan Intra-Uterine Contraceptive Devices Price by Application (2015-2020)
6.6 Japan Intra-Uterine Contraceptive Devices Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Intra-Uterine Contraceptive Devices Sales Forecast by Application (2021-2026)
6.6.2 Japan Intra-Uterine Contraceptive Devices Revenue Forecast by Application (2021-2026)
6.6.3 Japan Intra-Uterine Contraceptive Devices Price Forecast by Application (2021-2026)
7 North America
7.1 North America Intra-Uterine Contraceptive Devices Market Size YoY Growth 2015-2026
7.2 North America Intra-Uterine Contraceptive Devices Market Facts & Figures by Country
7.2.1 North America Intra-Uterine Contraceptive Devices Sales by Country (2015-2020)
7.2.2 North America Intra-Uterine Contraceptive Devices Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Intra-Uterine Contraceptive Devices Market Size YoY Growth 2015-2026
8.2 Europe Intra-Uterine Contraceptive Devices Market Facts & Figures by Country
8.2.1 Europe Intra-Uterine Contraceptive Devices Sales by Country
8.2.2 Europe Intra-Uterine Contraceptive Devices Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Intra-Uterine Contraceptive Devices Market Size YoY Growth 2015-2026
9.2 Asia Pacific Intra-Uterine Contraceptive Devices Market Facts & Figures by Country
9.2.1 Asia Pacific Intra-Uterine Contraceptive Devices Sales by Region (2015-2020)
9.2.2 Asia Pacific Intra-Uterine Contraceptive Devices Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Intra-Uterine Contraceptive Devices Market Size YoY Growth 2015-2026
10.2 Latin America Intra-Uterine Contraceptive Devices Market Facts & Figures by Country
10.2.1 Latin America Intra-Uterine Contraceptive Devices Sales by Country
10.2.2 Latin America Intra-Uterine Contraceptive Devices Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Intra-Uterine Contraceptive Devices Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Intra-Uterine Contraceptive Devices Market Facts & Figures by Country
11.2.1 Middle East and Africa Intra-Uterine Contraceptive Devices Sales by Country
11.2.2 Middle East and Africa Intra-Uterine Contraceptive Devices Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bayer AG
12.1.1 Bayer AG Corporation Information
12.1.2 Bayer AG Description and Business Overview
12.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer AG Intra-Uterine Contraceptive Devices Products Offered
12.1.5 Bayer AG Recent Development
12.2 Teva Pharmaceuticals Industries
12.2.1 Teva Pharmaceuticals Industries Corporation Information
12.2.2 Teva Pharmaceuticals Industries Description and Business Overview
12.2.3 Teva Pharmaceuticals Industries Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Pharmaceuticals Industries Intra-Uterine Contraceptive Devices Products Offered
12.2.5 Teva Pharmaceuticals Industries Recent Development
12.3 Mona Lisa N.V.
12.3.1 Mona Lisa N.V. Corporation Information
12.3.2 Mona Lisa N.V. Description and Business Overview
12.3.3 Mona Lisa N.V. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mona Lisa N.V. Intra-Uterine Contraceptive Devices Products Offered
12.3.5 Mona Lisa N.V. Recent Development
12.4 DKT International
12.4.1 DKT International Corporation Information
12.4.2 DKT International Description and Business Overview
12.4.3 DKT International Sales, Revenue and Gross Margin (2015-2020)
12.4.4 DKT International Intra-Uterine Contraceptive Devices Products Offered
12.4.5 DKT International Recent Development
12.5 Egemen International
12.5.1 Egemen International Corporation Information
12.5.2 Egemen International Description and Business Overview
12.5.3 Egemen International Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Egemen International Intra-Uterine Contraceptive Devices Products Offered
12.5.5 Egemen International Recent Development
12.6 Melbea AG
12.6.1 Melbea AG Corporation Information
12.6.2 Melbea AG Description and Business Overview
12.6.3 Melbea AG Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Melbea AG Intra-Uterine Contraceptive Devices Products Offered
12.6.5 Melbea AG Recent Development
12.7 Ocon Medical Ltd.
12.7.1 Ocon Medical Ltd. Corporation Information
12.7.2 Ocon Medical Ltd. Description and Business Overview
12.7.3 Ocon Medical Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Ocon Medical Ltd. Intra-Uterine Contraceptive Devices Products Offered
12.7.5 Ocon Medical Ltd. Recent Development
12.8 Pregna International Limited
12.8.1 Pregna International Limited Corporation Information
12.8.2 Pregna International Limited Description and Business Overview
12.8.3 Pregna International Limited Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pregna International Limited Intra-Uterine Contraceptive Devices Products Offered
12.8.5 Pregna International Limited Recent Development
12.9 Medical Engineering Corporation SA
12.9.1 Medical Engineering Corporation SA Corporation Information
12.9.2 Medical Engineering Corporation SA Description and Business Overview
12.9.3 Medical Engineering Corporation SA Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Medical Engineering Corporation SA Intra-Uterine Contraceptive Devices Products Offered
12.9.5 Medical Engineering Corporation SA Recent Development
12.10 SMB Corporation and Meril Life Sciences Pvt. Ltd.
12.10.1 SMB Corporation and Meril Life Sciences Pvt. Ltd. Corporation Information
12.10.2 SMB Corporation and Meril Life Sciences Pvt. Ltd. Description and Business Overview
12.10.3 SMB Corporation and Meril Life Sciences Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 SMB Corporation and Meril Life Sciences Pvt. Ltd. Intra-Uterine Contraceptive Devices Products Offered
12.10.5 SMB Corporation and Meril Life Sciences Pvt. Ltd. Recent Development
12.11 Bayer AG
12.11.1 Bayer AG Corporation Information
12.11.2 Bayer AG Description and Business Overview
12.11.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bayer AG Intra-Uterine Contraceptive Devices Products Offered
12.11.5 Bayer AG Recent Development
12.12 Sanghai Jolly Medical Education Co., Ltd
12.12.1 Sanghai Jolly Medical Education Co., Ltd Corporation Information
12.12.2 Sanghai Jolly Medical Education Co., Ltd Description and Business Overview
12.12.3 Sanghai Jolly Medical Education Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Sanghai Jolly Medical Education Co., Ltd Products Offered
12.12.5 Sanghai Jolly Medical Education Co., Ltd Recent Development
12.13 Bernstein Leibhard LLP
12.13.1 Bernstein Leibhard LLP Corporation Information
12.13.2 Bernstein Leibhard LLP Description and Business Overview
12.13.3 Bernstein Leibhard LLP Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Bernstein Leibhard LLP Products Offered
12.13.5 Bernstein Leibhard LLP Recent Development
12.14 Zheijang Daji Medical Instruments, Ltd.
12.14.1 Zheijang Daji Medical Instruments, Ltd. Corporation Information
12.14.2 Zheijang Daji Medical Instruments, Ltd. Description and Business Overview
12.14.3 Zheijang Daji Medical Instruments, Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Zheijang Daji Medical Instruments, Ltd. Products Offered
12.14.5 Zheijang Daji Medical Instruments, Ltd. Recent Development
12.15 Nimble International
12.15.1 Nimble International Corporation Information
12.15.2 Nimble International Description and Business Overview
12.15.3 Nimble International Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Nimble International Products Offered
12.15.5 Nimble International Recent Development
12.16 AME Line, Technico
12.16.1 AME Line, Technico Corporation Information
12.16.2 AME Line, Technico Description and Business Overview
12.16.3 AME Line, Technico Sales, Revenue and Gross Margin (2015-2020)
12.16.4 AME Line, Technico Products Offered
12.16.5 AME Line, Technico Recent Development
12.17 Cepeo
12.17.1 Cepeo Corporation Information
12.17.2 Cepeo Description and Business Overview
12.17.3 Cepeo Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Cepeo Products Offered
12.17.5 Cepeo Recent Development
12.18 Contraceptivos
12.18.1 Contraceptivos Corporation Information
12.18.2 Contraceptivos Description and Business Overview
12.18.3 Contraceptivos Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Contraceptivos Products Offered
12.18.5 Contraceptivos Recent Development
12.19 Injeflex Ind And Com Ltda
12.19.1 Injeflex Ind And Com Ltda Corporation Information
12.19.2 Injeflex Ind And Com Ltda Description and Business Overview
12.19.3 Injeflex Ind And Com Ltda Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Injeflex Ind And Com Ltda Products Offered
12.19.5 Injeflex Ind And Com Ltda Recent Development
12.20 Bersil
12.20.1 Bersil Corporation Information
12.20.2 Bersil Description and Business Overview
12.20.3 Bersil Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Bersil Products Offered
12.20.5 Bersil Recent Development
12.21 Amed
12.21.1 Amed Corporation Information
12.21.2 Amed Description and Business Overview
12.21.3 Amed Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Amed Products Offered
12.21.5 Amed Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Intra-Uterine Contraceptive Devices Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intra-Uterine Contraceptive Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Intra-Uterine Contraceptive Devices Market Segments
Table 2. Ranking of Global Top Intra-Uterine Contraceptive Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Intra-Uterine Contraceptive Devices Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Copper IUCD
Table 5. Major Manufacturers of Hormonal IUCD
Table 6. Global Intra-Uterine Contraceptive Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Intra-Uterine Contraceptive Devices Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Intra-Uterine Contraceptive Devices Sales by Regions 2015-2020 (K Units)
Table 9. Global Intra-Uterine Contraceptive Devices Sales Market Share by Regions (2015-2020)
Table 10. Global Intra-Uterine Contraceptive Devices Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Intra-Uterine Contraceptive Devices Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Intra-Uterine Contraceptive Devices Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Intra-Uterine Contraceptive Devices Sales Share by Manufacturers (2015-2020)
Table 14. Global Intra-Uterine Contraceptive Devices Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Intra-Uterine Contraceptive Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intra-Uterine Contraceptive Devices as of 2019)
Table 16. Intra-Uterine Contraceptive Devices Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Intra-Uterine Contraceptive Devices Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Intra-Uterine Contraceptive Devices Price (2015-2020) (USD/Unit)
Table 19. Intra-Uterine Contraceptive Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Intra-Uterine Contraceptive Devices Product Type
Table 21. Date of International Manufacturers Enter into Intra-Uterine Contraceptive Devices Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Intra-Uterine Contraceptive Devices Sales by Type (2015-2020) (K Units)
Table 24. Global Intra-Uterine Contraceptive Devices Sales Share by Type (2015-2020)
Table 25. Global Intra-Uterine Contraceptive Devices Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Intra-Uterine Contraceptive Devices Revenue Share by Type (2015-2020)
Table 27. Intra-Uterine Contraceptive Devices Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Intra-Uterine Contraceptive Devices Sales Share by Type (2021-2026)
Table 29. Global Intra-Uterine Contraceptive Devices Sales by Application (2015-2020) (K Units)
Table 30. Global Intra-Uterine Contraceptive Devices Sales Share by Application (2015-2020)
Table 31. Global Intra-Uterine Contraceptive Devices Sales Share by Application (2021-2026)
Table 32. Global Intra-Uterine Contraceptive Devices Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Intra-Uterine Contraceptive Devices Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Intra-Uterine Contraceptive Devices Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Intra-Uterine Contraceptive Devices Sales (K Units) of Key Companies (2015-2020)
Table 36. Japan Intra-Uterine Contraceptive Devices Sales Share by Company (2015-2020)
Table 37. Japan Intra-Uterine Contraceptive Devices Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Intra-Uterine Contraceptive Devices Sales (K Units) by Type (2015-2020)
Table 39. Japan Intra-Uterine Contraceptive Devices Sales Share by Type (2015-2020)
Table 40. Japan Intra-Uterine Contraceptive Devices Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Intra-Uterine Contraceptive Devices Price (K Units) by Type (2015-2020)
Table 42. Japan Intra-Uterine Contraceptive Devices Sales (K Units) by Type (2021-2026)
Table 43. Japan Intra-Uterine Contraceptive Devices Sales Share by Type (2021-2026)
Table 44. Japan Intra-Uterine Contraceptive Devices Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Intra-Uterine Contraceptive Devices Revenue Share by Type (2021-2026)
Table 46. Japan Intra-Uterine Contraceptive Devices Price (K Units) by Type (2021-2026)
Table 47. Japan Intra-Uterine Contraceptive Devices Sales (K Units) by Application (2015-2020)
Table 48. Japan Intra-Uterine Contraceptive Devices Sales Share by Application (2015-2020)
Table 49. Japan Intra-Uterine Contraceptive Devices Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Intra-Uterine Contraceptive Devices Sales (K Units) by Application (2021-2026)
Table 51. Japan Intra-Uterine Contraceptive Devices Sales Share by Application (2021-2026)
Table 52. Japan Intra-Uterine Contraceptive Devices Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Intra-Uterine Contraceptive Devices Revenue Share by Application (2021-2026)
Table 54. North America Intra-Uterine Contraceptive Devices Sales by Country (2015-2020) (K Units)
Table 55. North America Intra-Uterine Contraceptive Devices Sales Market Share by Country (2015-2020)
Table 56. North America Intra-Uterine Contraceptive Devices Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Intra-Uterine Contraceptive Devices Revenue Market Share by Country (2015-2020)
Table 58. Europe Intra-Uterine Contraceptive Devices Sales by Country (2015-2020) (K Units)
Table 59. Europe Intra-Uterine Contraceptive Devices Sales Market Share by Country (2015-2020)
Table 60. Europe Intra-Uterine Contraceptive Devices Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Intra-Uterine Contraceptive Devices Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Intra-Uterine Contraceptive Devices Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Intra-Uterine Contraceptive Devices Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Intra-Uterine Contraceptive Devices Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Intra-Uterine Contraceptive Devices Revenue Market Share by Region (2015-2020)
Table 66. Latin America Intra-Uterine Contraceptive Devices Sales by Country (2015-2020) (K Units)
Table 67. Latin America Intra-Uterine Contraceptive Devices Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Intra-Uterine Contraceptive Devices Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Intra-Uterine Contraceptive Devices Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Intra-Uterine Contraceptive Devices Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Intra-Uterine Contraceptive Devices Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Intra-Uterine Contraceptive Devices Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Intra-Uterine Contraceptive Devices Revenue Market Share by Country (2015-2020)
Table 74. Bayer AG Corporation Information
Table 75. Bayer AG Description and Business Overview
Table 76. Bayer AG Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bayer AG Intra-Uterine Contraceptive Devices Product
Table 78. Bayer AG Recent Development
Table 79. Teva Pharmaceuticals Industries Corporation Information
Table 80. Teva Pharmaceuticals Industries Description and Business Overview
Table 81. Teva Pharmaceuticals Industries Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Teva Pharmaceuticals Industries Product
Table 83. Teva Pharmaceuticals Industries Recent Development
Table 84. Mona Lisa N.V. Corporation Information
Table 85. Mona Lisa N.V. Description and Business Overview
Table 86. Mona Lisa N.V. Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Mona Lisa N.V. Product
Table 88. Mona Lisa N.V. Recent Development
Table 89. DKT International Corporation Information
Table 90. DKT International Description and Business Overview
Table 91. DKT International Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. DKT International Product
Table 93. DKT International Recent Development
Table 94. Egemen International Corporation Information
Table 95. Egemen International Description and Business Overview
Table 96. Egemen International Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Egemen International Product
Table 98. Egemen International Recent Development
Table 99. Melbea AG Corporation Information
Table 100. Melbea AG Description and Business Overview
Table 101. Melbea AG Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Melbea AG Product
Table 103. Melbea AG Recent Development
Table 104. Ocon Medical Ltd. Corporation Information
Table 105. Ocon Medical Ltd. Description and Business Overview
Table 106. Ocon Medical Ltd. Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Ocon Medical Ltd. Product
Table 108. Ocon Medical Ltd. Recent Development
Table 109. Pregna International Limited Corporation Information
Table 110. Pregna International Limited Description and Business Overview
Table 111. Pregna International Limited Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Pregna International Limited Product
Table 113. Pregna International Limited Recent Development
Table 114. Medical Engineering Corporation SA Corporation Information
Table 115. Medical Engineering Corporation SA Description and Business Overview
Table 116. Medical Engineering Corporation SA Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Medical Engineering Corporation SA Product
Table 118. Medical Engineering Corporation SA Recent Development
Table 119. SMB Corporation and Meril Life Sciences Pvt. Ltd. Corporation Information
Table 120. SMB Corporation and Meril Life Sciences Pvt. Ltd. Description and Business Overview
Table 121. SMB Corporation and Meril Life Sciences Pvt. Ltd. Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. SMB Corporation and Meril Life Sciences Pvt. Ltd. Product
Table 123. SMB Corporation and Meril Life Sciences Pvt. Ltd. Recent Development
Table 124. Medu Scientific Ltd, China RH Contraceptives Co., Ltd Corporation Information
Table 125. Medu Scientific Ltd, China RH Contraceptives Co., Ltd Description and Business Overview
Table 126. Medu Scientific Ltd, China RH Contraceptives Co., Ltd Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Medu Scientific Ltd, China RH Contraceptives Co., Ltd Product
Table 128. Medu Scientific Ltd, China RH Contraceptives Co., Ltd Recent Development
Table 129. Sanghai Jolly Medical Education Co., Ltd Corporation Information
Table 130. Sanghai Jolly Medical Education Co., Ltd Description and Business Overview
Table 131. Sanghai Jolly Medical Education Co., Ltd Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Sanghai Jolly Medical Education Co., Ltd Product
Table 133. Sanghai Jolly Medical Education Co., Ltd Recent Development
Table 134. Bernstein Leibhard LLP Corporation Information
Table 135. Bernstein Leibhard LLP Description and Business Overview
Table 136. Bernstein Leibhard LLP Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Bernstein Leibhard LLP Product
Table 138. Bernstein Leibhard LLP Recent Development
Table 139. Zheijang Daji Medical Instruments, Ltd. Corporation Information
Table 140. Zheijang Daji Medical Instruments, Ltd. Description and Business Overview
Table 141. Zheijang Daji Medical Instruments, Ltd. Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Zheijang Daji Medical Instruments, Ltd. Product
Table 143. Zheijang Daji Medical Instruments, Ltd. Recent Development
Table 144. Nimble International Corporation Information
Table 145. Nimble International Description and Business Overview
Table 146. Nimble International Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Nimble International Product
Table 148. Nimble International Recent Development
Table 149. AME Line, Technico Corporation Information
Table 150. AME Line, Technico Description and Business Overview
Table 151. AME Line, Technico Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. AME Line, Technico Product
Table 153. AME Line, Technico Recent Development
Table 154. Cepeo Corporation Information
Table 155. Cepeo Description and Business Overview
Table 156. Cepeo Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Cepeo Product
Table 158. Cepeo Recent Development
Table 159. Contraceptivos Corporation Information
Table 160. Contraceptivos Description and Business Overview
Table 161. Contraceptivos Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Contraceptivos Product
Table 163. Contraceptivos Recent Development
Table 164. Injeflex Ind And Com Ltda Corporation Information
Table 165. Injeflex Ind And Com Ltda Description and Business Overview
Table 166. Injeflex Ind And Com Ltda Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 167. Injeflex Ind And Com Ltda Product
Table 168. Injeflex Ind And Com Ltda Recent Development
Table 169. Bersil Corporation Information
Table 170. Bersil Description and Business Overview
Table 171. Bersil Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 172. Bersil Product
Table 173. Bersil Recent Development
Table 174. Amed Corporation Information
Table 175. Amed Description and Business Overview
Table 176. Amed Intra-Uterine Contraceptive Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 177. Amed Product
Table 178. Amed Recent Development
Table 179. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 180. Key Challenges
Table 181. Market Risks
Table 182. Main Points Interviewed from Key Intra-Uterine Contraceptive Devices Players
Table 183. Intra-Uterine Contraceptive Devices Customers List
Table 184. Intra-Uterine Contraceptive Devices Distr
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs